Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Because GLP-1 agonists independently reduce hepatic lipogenesis and improve insulin sensitivity, which overlaps mechanistically with the lipotropic pathway
Pfizer terminated lotiglipron in October 2023 due to dose-dependent liver enzyme elevations, and subsequently discontinued danuglipron in April 2025 after a single case of potential drug-induced liver injury was identified in a dose-optimization study
Ingredients Ratiopharm L-Carnitine 45 Gram Weight Loss Injection L-Carnitine:- An amino acid derivative that plays a crucial role in the production of energy by transporting fatty acids into the mitochondria
For more information on Ro's Body Membership and full suite of GLP-1 options, visit Ro.co/weightloss About Ro Ro is a direct-to-patient healthcare company with a mission of helping patients achieve their health goals by delivering the easiest, most effective care possible
